Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer. - Wikidata - wikimedia - TriplyDB

Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer.

Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer.

http://www.wikidata.org/entity/Q45091068

about

Chemotherapy-induced peripheral neurotoxicity: a critical analysis Review of systemic therapies for locally advanced and metastatic rectal cancer Chemotherapy-induced neuropathies-a growing problem for patients and health care providers Mitotoxicity in distal symmetrical sensory peripheral neuropathies Pain in cancer survivors Comparison of oxaliplatin and paclitaxel-induced neuropathy (Alliance A151505).Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy.[EXPRESS] Ion channels and neuronal hyperexcitability in chemotherapy-induced peripheral neuropathy; cause and effect?Anti-hyperalgesic effects of a novel TRPM8 agonist in neuropathic rats: a comparison with topical menthol.Neuropathic symptoms, quality of life, and clinician perception of patient care in medical oncology outpatients with colorectal, breast, lung, and prostate cancer.Platinum-induced neurotoxicity and preventive strategies: past, present, and future Combining curcumin (C3-complex, Sabinsa) with standard care FOLFOX chemotherapy in patients with inoperable colorectal cancer (CUFOX): study protocol for a randomised control trial.Neuropathic Symptoms and Their Risk Factors in Medical Oncology Outpatients With Colorectal vs. Breast, Lung, or Prostate Cancer: Results From a Prospective Multicenter Study.Clinical Course of Oxaliplatin-Induced Neuropathy: Results From the Randomized Phase III Trial N08CB (Alliance).Preventive effect of oral goshajinkigan on chronic oxaliplatin-induced hypoesthesia in rats MC11C4: a pilot randomized, placebo-controlled, double-blind study of venlafaxine to prevent oxaliplatin-induced neuropathy.Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN).The Effect of Anakinra on Paclitaxel-Induced Peripheral Neuropathic Pain in Rats Electrophysiological and morphological changes in colonic myenteric neurons from chemotherapy-treated patients: a pilot study.Chemotherapy-induced peripheral neuropathy in adults: a comprehensive update of the literature.Oxaliplatin-induced peripheral neuropathy's effects on health-related quality of life of colorectal cancer survivors.Chemotherapy-induced polyneuropathy: major agents and assessment by questionnaires.Chemotherapy-induced peripheral neurotoxicity (CIPN): what we need and what we know.Factors associated with the development and severity of oxaliplatin-induced peripheral neuropathy: a systematic review.Panitumumab-Conjugated Pt-Drug Nanomedicine for Enhanced Efficacy of Combination Targeted Chemotherapy against Colorectal Cancer.Differential Effects of Polymer-Surface Decoration on Drug Delivery, Cellular Retention, and Action Mechanisms of Functionalized Mesoporous Silica Nanoparticles.Preventing oxaliplatin-induced neurotoxicity: rationale and design of phase Ib randomized, double-blind, placebo-controlled, cross-over trials for early clinical evaluation of investigational therapeutics.Peripheral neuropathy in colorectal cancer survivors: the influence of oxaliplatin administration. Results from the population-based PROFILES registry.Reliability and accuracy of quantitative sensory testing for oxaliplatin-induced neurotoxicity.Pain in chemotherapy-induced peripheral neurotoxicity.Genetic determinants of chronic oxaliplatin-induced peripheral neurotoxicity: a genome-wide study replication and meta-analysis.Chronic Oxaliplatin-Based Chemotherapy in a Primary Ampullary Adenocarcinoma Patient without Significant Peripheral Neuropathy: Case Report and Literature Review.Analgesic effects of clinically used compounds in novel mouse models of polyneuropathy induced by oxaliplatin and cisplatin.Current View in Platinum Drug Mechanisms of Peripheral Neurotoxicity.Voltage-gated sodium channel polymorphisms play a pivotal role in the development of oxaliplatin-induced peripheral neurotoxicity: results from a prospective multicenter study.Corneal confocal microscopy in patients with oxaliplatin-induced peripheral neuropathy.Updates on Oxaliplatin-Induced Peripheral Neurotoxicity (OXAIPN).Association of Voltage-Gated Sodium Channel Genetic Polymorphisms with Oxaliplatin-Induced Chronic Peripheral Neuropathy in South Indian Cancer Patients Efficacy of a Novel Sigma-1 Receptor Antagonist for Oxaliplatin-Induced Neuropathy: A Randomized, Double-Blind, Placebo-Controlled Phase IIa Clinical Trial.Pharmacokinetic and toxicodynamic evaluation of oxaliplatin-induced neuropathy and hematological toxicity in rats.

P2860

Q27010318-DE858862-0468-49B1-9764-DB6A0F811340 Q27021105-FEB8A198-0D63-4FCD-B4A0-231418863198 Q28818565-BF02D4CC-FA99-47F7-AF48-9F7F49B7A09B Q28834071-B2EDD9BF-5A27-4D48-BCA4-7CDD469BCCA2 Q33650576-F0313240-7153-4C0D-916E-00C8540D7831 Q33711444-AD35B999-066A-4097-AF51-C7481F342414 Q33744706-DE434E6B-CF13-41BC-8588-08F7B5A04AFB Q33824948-9A68DE0E-7516-4CCF-90B8-D67173A4F5CF Q34451607-77E2C815-C9E9-4C6D-B341-281DD2310BD3 Q35002187-4009BF92-BD5B-4166-AF68-4159DD786C7D Q35345734-61C29B13-0BBA-4F9A-BAEA-A8FBC32A8D24 Q35358778-3B68D96A-845E-4465-AE63-E820AB8FB110 Q35778696-B7FBA3F0-E0B8-400E-8291-FD4D10432065 Q36162504-0AC0A11D-64A9-4F92-931B-5C47E21265BB Q36254642-BD366D82-D1B8-4209-97A1-ECA8DDBFBC9F Q37082272-68284C32-59E6-4E4A-AD7A-7343A5711185 Q37399781-D17D910C-EC5A-4AA8-926D-55425B94BF99 Q37551822-132114CE-43AA-4669-9619-D3AFD1488EAC Q37561412-CF2D7CD2-B799-4F30-88ED-C74D02A9F8B9 Q37659699-76CA6813-035F-40E8-8BCE-0D3AECF32723 Q37744263-D9C61DD8-9A65-4A52-A063-F90C3776E2A1 Q38209390-BF923D4F-25DC-4321-90D4-4DD66B133DA6 Q38224422-9FEA14C7-4767-4F21-B795-30DB5C95C924 Q38707400-6E373347-A046-4737-96FA-6DD9D581DBE1 Q38832881-F6F7FEE5-B3D1-49AD-8FC9-1C82510BF103 Q38845880-ADBF026F-5475-45BA-A70F-1A8DF9D162BF Q38931361-03AE4F30-54B1-4AEC-9F0C-5F079475DB64 Q39095046-EDFB27D0-7F2C-423B-90B8-930C53A06B87 Q39113665-E0EA87E7-42DE-490D-AE88-A2EA4CFA6809 Q39363713-3D7A9328-5F4B-402B-92F7-D146CCD01B19 Q41095276-A869F89E-24BE-4453-AC62-0B0BF74DEB08 Q41488055-588DA28A-3B47-4795-821F-37122B3EC784 Q41852990-D6101ABB-5313-4C63-9A77-725B17D1E88D Q42361420-F307CD3A-71B8-432E-9C7B-95321BF01EF9 Q44304377-19E16172-9B1E-4202-A6DD-8DB4B7DF5210 Q44718187-FC7E3B7D-3CBE-4E60-A2DF-715954E33262 Q45356332-499CB4C9-C9C4-450E-B869-C0599349C2FF Q47207401-A3EAF865-C861-483E-A15A-4D33CD4322B1 Q47266458-80F38937-394D-487F-8E4B-6A02C4E5E32E Q47430728-D1D778CA-69E8-4711-A9BA-45A5F35A61D9

P2860

Clinical pattern and associations of oxaliplatin acute neurotoxicity: a prospective study in 170 patients with colorectal cancer.

http://www.wikidata.org/entity/Q45091068

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh-hant

name

Clinical pattern and associati ...... tients with colorectal cancer.

@en

Clinical pattern and associati ...... tients with colorectal cancer.

@nl

type

label

Clinical pattern and associati ...... tients with colorectal cancer.

@en

Clinical pattern and associati ...... tients with colorectal cancer.

@nl

prefLabel

Clinical pattern and associati ...... tients with colorectal cancer.

@en

Clinical pattern and associati ...... tients with colorectal cancer.

@nl

P1433

Q45091068-CE599DB0-0F78-4C77-942C-9099A3829D1A

P1476

Q45091068-7635D5A2-0A2D-4D6A-9021-4EB914A7594E

P2093

Q45091068-0EB0D7ED-08B4-4747-A0AD-6193B13BCEC8

Q45091068-1296AADE-55E5-4DC2-8D88-40C271BF1B1F

Q45091068-744B5CA7-6924-460D-98AE-B2604120713F

Q45091068-A0D1214B-B094-4B1E-989F-E185E1D0DC91

Q45091068-B672A793-7FD5-4C1E-8BFA-0AB87FB8C32B

Q45091068-DD93F5F1-73B6-4E76-B3B8-26705798CB1F

Q45091068-ED91A1BE-299D-4993-B474-1CF82CE3E708

Q45091068-F34DC4D6-C41A-4C55-99C7-2C54032C2B9F

Q45091068-FC778D39-530C-4AC1-9A51-A48D02A121B8

P2860

Q45091068-102E75FB-9D6D-4E1F-B913-4AF39EB3A71F

Q45091068-18AE8DDC-8057-4782-821D-D5E881A6B4D8

Q45091068-4889F904-AE52-46BE-B103-6870313AD997

Q45091068-4FCF1836-250D-42D0-83EA-E0EBB9DBDF06

Q45091068-51CE2FCD-D73C-4A59-A3EC-45AAB6908CDF

Q45091068-5D186674-76E3-446D-8691-C7E04E76D632

Q45091068-5DC59854-C25D-4AA9-8908-2C0F1E558974

Q45091068-5F470D96-0944-4857-B5D6-DA9D4F46C115

Q45091068-67A97E8F-CA03-4B8C-9DAB-06E2CFFA4873

Q45091068-813EE665-FEAE-4FFF-A764-BEAEB8CBBFE4

P304

Q45091068-646918F9-E209-4D24-B784-6044DEC3001A

P31

Q45091068-9758387B-0CEC-4C1F-98E6-E3D03263D177

P356

Q45091068-4CC77560-FA44-4F4D-B330-926471DF95F3

P407

Q45091068-5F65CA91-F797-483D-9786-2FFF7461618F

P433

Q45091068-44A9A86C-281A-4B16-8ABC-980C70C1DD1A

P478

Q45091068-19A17CAC-C3C0-44A0-BD0D-B97ABBE7895A

P50

Q45091068-2436E95F-2CCC-4B10-9407-57A98E0425B0

Q45091068-4104D53F-6812-4482-932F-CDD6307E6F15

Q45091068-99AD905F-79AC-4023-A7CD-1C48C17515E4

Q45091068-FA440CF9-5112-4BE2-8ECE-9FF24300543A

P577

Q45091068-7166B862-F330-4636-B631-C6825D3D1E4F

P5875

Q45091068-7AF23014-0690-4F86-A1E9-4098CB3D1318

P698

Q45091068-34888915-0564-46B2-BB85-328AA8BE081F

P921

Q45091068-1BEBE2CE-6A87-4C7D-BFF5-2308B70FB9FA

Q45091068-AFE01D1D-49A8-415F-B8D1-85A54258C62A

Q45091068-E02A6B1C-A389-4B83-99D2-275835A2F37D

P356

P1433

P1476

Clinical pattern and associati ...... tients with colorectal cancer.

@en

P2093

Andreas A Argyriou

http://www.w3.org/2001/XMLSchema#string

Chiara Briani

http://www.w3.org/2001/XMLSchema#string

Cristina Santos

http://www.w3.org/2001/XMLSchema#string

Diego Cortinovis

http://www.w3.org/2001/XMLSchema#string

Haralabos P Kalofonos

http://www.w3.org/2001/XMLSchema#string

Konstantinos Papadimitriou

http://www.w3.org/2001/XMLSchema#string

Marina Cazzaniga

http://www.w3.org/2001/XMLSchema#string

Marta Campagnolo

http://www.w3.org/2001/XMLSchema#string

Roser Velasco

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2010

Comparative anticonvulsant and mechanistic profile of the established and newer antiepileptic drugs.

Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.

XELOX (capecitabine plus oxaliplatin): active first-line therapy for patients with metastatic colorectal cancer.

Oxaliplatin-related neurotoxicity: how and why?

Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies.

Longitudinal assessment of oxaliplatin-induced neuropathy.

A review of oxaliplatin and its clinical use in colorectal cancer.

Anticancer drug oxaliplatin induces acute cooling-aggravated neuropathy via sodium channel subtype Na(V)1.6-resurgent and persistent current.

A review on oxaliplatin-induced peripheral nerve damage.

P304

438-444

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/CNCR.27732

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

119

http://www.w3.org/2001/XMLSchema#string

P50

Francesca Bergamo

Guido Cavaletti

P577

2012-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

229075083

http://www.w3.org/2001/XMLSchema#string

P698

22786764

http://www.w3.org/2001/XMLSchema#string

P921

colorectal cancer